Oncopeptides strengthens its corporate communications function by appointing Rolf Gulliksen as Global Head of Corporate Communications

STOCKHOLM — April 2, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Rolf Gulliksen has been appointed global head of corporate communications. Rolf has 30 years of experience from senior corporate communications roles in the life science industry and consultancy.Prior to joining Oncopeptides, he served as head of corporate communications at Hansa Biopharma. He will be a member of Oncopeptides’ Management Team and will start today. “Communication will be a critical function to support our growing business and presence in key markets and pave the way for our first